MediLumine’s Fenestra® imaging agents for preclinical computed tomography will be presented at the upcoming WMIC.
Fenestra® LC and Fenestra® VC imaging agents are used for a wide array of applications in preclinical computed tomography and molecular imaging. These hepatocyte selective nanoemulsions help to enable co-registration of soft tissue CT data for multimodal molecular imaging, quantification of metastatic tumor burdens, 4D imaging for characterization of murine cardiovascular disease and quantitative assessments of anti-angiogenic therapies.
We are thrilled to announce that CJ215, a tumor labeling dye, is now available through MediLumine. Developed by ProImaging (Paris, France), CJ215 is making waves
MediLumine Announces Collaboration with Dyomics We are excited to announce that MediLumine has entered into a collaboration with Dyomics to enhance our product offerings with
Copyright © 2024 · MediLumine, Inc · All Rights Reserved
